Intravenous Thrombolysis in Patients With Cervical Artery Dissection: A Secondary Analysis of the STOP-CAD Study
Liqi Shu,Favour Akpokiere,Daniel M Mandel,Thalia S Field,Christopher R Leon Guerrero,Nils Henninger,Jayachandra Muppa,Muhammad Affan,Omair U Haq Lodhi,Mirjam R Heldner,Kateryna Antonenko,David J Seiffge,Marcel Arnold,Setareh Salehi Omran,Ross Crandall,Evan Lester,Diego López-Mena,Antonio Arauz,Ahmad Nehme,Marion Boulanger,Emmanuel Touzé,João André Sousa,João Sargento-Freitas,Vasco Barata,Paulo Castro-Chaves,Maria T Brito,Muhib Khan,Dania Mallick,Aaron Rothstein,Ossama Khazaal,Josefin E Kaufmann,Stefan T Engelter,Christopher Traenka,Diana Aguiar de Sousa,Mafalda D Soares,Sara B Rosa,Lily Zhou,Preet Gandhi,Steven Mancini,Issa Metanis,Ronen R Leker,Kelly Pan,Vishnu Dantu,Karl Baumgartner,Tina M Burton,Regina Von Rennenberg,Christian H Nolte,Richard Choi,Jason MacDonald,Reza Bavarsad Shahripour,Xiaofan Guo,Malik Ghannam,Mohammad Almajali,Edgar A Samaniego,Bastien Rioux,Faycal Zine-Eddine,Alexandre Poppe,Ana C Fonseca,Maria F Baptista,Diana Cruz,Michele Romoli,Giovanna De Marco,Marco Longoni,Zafer Keser,Kim J Griffin,Lindsey Kuohn,Jennifer A Frontera,Jordan Y Amar,James A Giles,Marialuisa Zedde,Rosario Pascarella,Ilaria Grisendi,Hipolito Nzwalo,David S Liebeskind,Amir Molaie,Annie Cavalier,Wayneho Kam,Brian Mac Grory,Sami Al Kasab,Mohammad Anadani,Kimberly P Kicielinski,Ali Eltatawy,Lina Chervak,Roberto Chulluncuy Rivas,Yasmin N Aziz,Eva A Mistry,Ekaterina Bakradze,Thanh L Tran,Marc Rodrigo-Gisbert,Manuel Requena,Faddi G Saleh Velez,Jorge Ortiz Garcia,Varsha Muddasani,Adam de Havenon,Sebastian Sanchez,Venugopalan Y Vishnu,Sridhara Yaddanapudi,Latasha Adams,Abigail Browngoehl,Tamra Ranasinghe,Randy Dunston,Zachary Lynch,Mary Penckofer,James E Siegler,Silvia Mayer,Joshua Z Willey,Adeel S Zubair,Yee Kuang Cheng,Richa Sharma,João Pedro Marto,Danna Krupka,Piers Klein,Thanh N Nguyen,Syed Daniyal Asad,Zoha Sarwat,Anvesh Balabhadra,Shivam Patel,Thais Secchi,Sheila C Martins,Gabriel P Mantovani,Young Dae Kim,Balaji Krishnaiah,Cheran Elangovan,Sivani Lingam,Abid Y Qureshi,Sebastian Fridman,Alonso Alvarado,Farid Khasiyev,Guillermo Linares,Marina Mannino,Valeria Terruso,Argyro Tountopoulou,Vasileios Tentolouris-Piperas,Manuel M Martinez-Marino,Victor Carrasco Wall,Fransisca Indraswari,Sleiman E El Jamal,Shilin Liu,Min Zhou,Muhammad M Alvi,Farman Ali,Mohammed Sarvath,Rami Z Morsi,Tareq Kass-Hout,Feina Shi,Jinhua Zhang,Dilraj Sokhi,Jamil Said,Newnex Mongare,Alexis N Simpkins,Roberto Gomez,Shayak Sen,Mohammad Ghani,Marwa Elnazeir,Runqi Wangqin,Han Xiao,Narendra S Kala,Farhan Khan,Christoph Stretz,Nahid Mohammadzadeh,Eric D Goldstein,Karen Furie,Shadi Yaghi
DOI: https://doi.org/10.1212/WNL.0000000000209843
IF: 9.9
2024-10-08
Neurology
Abstract:Objectives: Cervical artery dissection (CeAD) accounts for 25% of ischemic strokes in young adults. This study evaluated the benefits and harms of intravenous thrombolysis (IVT) in patients presenting with spontaneous CeAD and acute ischemic stroke symptoms. Methods: This analysis used data from the retrospective STOP-CAD study and included patients with spontaneous CeAD who presented within 1 day of acute ischemic stroke symptoms. Patients were dichotomized into those who received IVT and those managed without IVT. We assessed the association between IVT and 90-day functional independence (modified Rankin Scale scores 0-2) and the incidence of symptomatic intracranial hemorrhage (ICH, defined as ICH causing new or worsening neurologic symptoms within 72 hours after CeAD diagnosis). Results: This study included 1,653 patients from the original STOP-CAD cohort of 4,023. The median age was 49 years, and 35.1% were women; 512 (31.0%) received IVT. IVT was associated with 90-day functional independence (adjusted odds ratio [aOR] = 1.67, 95% CI 1.23-2.28, p = 0.001), but not with symptomatic ICH (aOR = 1.52, 95% CI 0.79-2.92, p = 0.215). Discussion: In patients with spontaneous CeAD and suspected ischemic stroke, IVT improved functional outcomes, without increasing symptomatic ICH risk. These findings support current guideline recommendations to consider thrombolysis for otherwise eligible patients with CeAD. Classification of evidence: This study provides Class III evidence that IVT significantly increases the probability of 90-day functional independence in patients with CeAD.